1. HYPOLIPIDEMIC EFFECT OF A NEW ARYLOXY COMPOUND, S-8527, IN EXPERIMENTAL ANIMALS
- Author
-
Kotaro Suzuki, Hiroshi Nakatani, and Shunji Aono
- Subjects
Glycerol ,Male ,medicine.medical_specialty ,Time Factors ,Carboxylic Acids ,Hyperlipidemias ,Polyethylene Glycols ,Mice ,chemistry.chemical_compound ,Species Specificity ,Cyclohexanes ,Internal medicine ,Hyperlipidemia ,medicine ,Animals ,Clofibrate ,Triglycerides ,Hypolipidemic Agents ,Pharmacology ,Dose-Response Relationship, Drug ,Triglyceride ,Cholesterol ,Phenyl Ethers ,medicine.disease ,Effective dose (pharmacology) ,Rats ,Compound s ,Endocrinology ,Liver ,chemistry ,Rabbits ,medicine.drug - Abstract
The hypolipidemic action of 1,1-bis [4'-(l "-carboxy-1 "-methyIpropoxy)-phenyl] cyclohexane (S-8527) was studied in rats, mice and rabbits under various experimental conditions to compare the effects with those of clofibrate. Oral ingestion of S-8527 to normal rats for 7 days lowered serum triglycerides and cholesterol by about 27% at 1 mg/kg and 20% at 3 mg/kg, respectively. The hypolipidemic effect of S-8527 was considered to be twenty to thirty times more potent than that of clofibrate but a hepatomegaltc effect of S-8527 was not observed at its effective dose ranging from 1 to 30 mg/kg. S-8527 at 3 mg/kg decreased liver triglyceride concentration by about 20% but the decrease of triglyceride concentration was not observed in clofibrate treated groups. Liver cholesterol concentration was not decreased with any of the doses of S-8527 while clofibrate decreased liver cholesterol concentration by about 20% at 300 mg/kg. However, there were no differences in total content of cholesterol in liver between S-8527 and clofibrate treated groups. With Triton injected rats, a single oral dose of 100 mg/kg of S-8527 depressed the increase of serum triglycerides by about 50% while clofibrate did not. In glycerol-fed rats, S-8527 decreased serum and liver triglycerides more effectively than clofibrate, and in normal mice and cholesterol-fed mice, S-8527 was found to be more active than clofibrate, however the hepatomegalic effect of S-8527 was less than that of clofibrate. Hypolipidemic effects in rabbits were not observed with either S-8527 or clofibrate.
- Published
- 1974